about
Gabapentin but not vigabatrin is effective in the treatment of acquired nystagmus in multiple sclerosis: How valid is the GABAergic hypothesis?Retinal nerve fibre layer measurements and optic nerve head analysis in multiple sclerosis patients.Electroretinographic modifications induced by agomelatine: a novel avenue to the understanding of the claimed antidepressant effect of the drug?Long-term effects of transcranial direct-current stimulation in chronic post-stroke aphasia: a pilot study.Resting state in Alzheimer's disease: a concurrent analysis of Flash-Visual Evoked Potentials and quantitative EEG.The effect of cannabinoids on the stretch reflex in multiple sclerosis spasticity.Risk Stratification for Recurrence and Mortality in Embolic Stroke of Undetermined Source.Age- and sex-specific analysis of patients with embolic stroke of undetermined source.Dramatic rebounds of MS during pregnancy following fingolimod withdrawal.Neurological complications of pregnancy.Minocycline in neurological diseases.Pseudo plus-minus lid syndrome.Catatonic features in major depression relieved by electroconvulsive treatment: parallel evaluation of the status of platelet serotonin transporter.Using STN DBS and medication reduction as a strategy to treat pathological gambling in Parkinson's disease.Real-time artifact filtering in continuous VEPs/fMRI recording.Interhemispheric subdural haematoma from ruptured aneurysm: a case report.Electroretinographic assessment in major depressed patients receiving duloxetine: might differences between responders and non-responders indicate a differential biological background?Early Recurrence and Major Bleeding in Patients With Acute Ischemic Stroke and Atrial Fibrillation Treated With Non-Vitamin-K Oral Anticoagulants (RAF-NOACs) Study.Spasticity and spastic dystonia: the two faces of velocity-dependent hypertonia.On the role of visual electrophysiology in Parkinson's disease.Prediction of Early Recurrent Thromboembolic Event and Major Bleeding in Patients With Acute Stroke and Atrial Fibrillation by a Risk Stratification Schema: The ALESSA Score Study.Eye closure affects flash VEP latency in dementia.Urinary JCV-DNA Testing during Natalizumab Treatment May Increase Accuracy of PML Risk StratificationElectrophysiological evidence for visuocognitive dysfunction in younger non Caucasian patients with Parkinson's diseaseElectrophysiological detection of "silent" plaques in the optic pathwaysAphasic status epilepticus in multiple sclerosisParkinson's disease changes the balance of onset and offset visual responses: an evoked potential studyOcular myasthenia mimicking a one-and-a-half syndromeGabapentin as treatment for hemifacial spasmThe diagnostic value of vestibular evoked myogenic potentials in multiple sclerosisA case of secondary syphilis presenting as optic neuritisPre-orgasmic sexual headache responsive to topiramate: a case report
P50
Q28367126-F1418A17-0022-4BE5-AF28-9A9EBB20BD03Q30835940-65659431-519B-46DE-BE34-701879AFC25CQ33685314-75C115FD-1619-487A-89E5-0602EFC19C44Q34336301-7A2BF952-8930-4E6D-A02B-6B4A82CDDC06Q34494442-2F83A6DD-D237-424D-BC4F-83B9E3D60AC3Q38891717-BD5DD643-4D8C-4354-82A0-B3E55998A68BQ39505673-73EBF1BF-6F13-4AAD-A879-32966C158118Q40131369-5AE90CB1-5EF3-4EF0-A006-B7179CAB7AB1Q41162800-A80E5184-AA75-4D3D-9D6E-1517706E992AQ41725499-1858D408-BE0D-4C3F-B4F8-10373C3406A6Q45275038-4ABA0881-591B-4A01-A121-7629BF852F1CQ46015904-2AC308B8-E360-454F-9A31-94C690441804Q46371747-C3366F0C-5C0E-4322-8E6F-E291D3271BC8Q48393586-A7E1D634-13D1-43B0-9191-9D5C68CEB5F4Q48485160-9DCAF101-B10E-4FC1-B5EB-006F1CC7777EQ48546777-E76EE2B1-CCB5-44C7-BAA6-C5FC7C1FC484Q48811591-B6190A52-8386-4AED-A8A2-AFDFBD2B1F7BQ49197579-C9BA6BC3-5558-464A-A63F-B667E332E400Q49555262-61507A3A-A67C-4BF1-A877-9F5944B95A56Q50057451-027BE35E-4066-4647-8DA0-DCC1B793D2B0Q50862098-FAE7584F-BD76-44B1-834F-40DDF6BB3643Q54009956-49D9B207-9035-49CA-93E6-0D7149C4AB4CQ61657742-AABCB804-9EF6-4DFA-8216-DC01A45001AFQ67218925-2D5DE06B-3B7F-4310-99D1-236589A6725BQ69460490-70A967A2-11AB-4F19-8604-F423C2E5D028Q71858309-2D198796-FCDB-4C10-846C-21254AE2BA27Q73935617-AF1106AB-BE81-4454-A9C5-408D11994C45Q77297178-11CDBC3D-9943-4AB4-8A07-C57678898C8DQ77961728-84A9E557-1BBC-4958-837B-FB8EB7FB95BFQ80136190-455527AD-8CD9-4E2D-8142-9E797E28BE92Q83026922-5A60030E-2090-4D15-995D-804681463141Q84406931-73B79AD1-93BE-46F6-8D81-7490FCBC4F7F
P50
description
hulumtues
@sq
onderzoeker
@nl
researcher
@en
հետազոտող
@hy
name
Fabio Bandini
@ast
Fabio Bandini
@en
Fabio Bandini
@es
Fabio Bandini
@nl
Fabio Bandini
@sl
type
label
Fabio Bandini
@ast
Fabio Bandini
@en
Fabio Bandini
@es
Fabio Bandini
@nl
Fabio Bandini
@sl
prefLabel
Fabio Bandini
@ast
Fabio Bandini
@en
Fabio Bandini
@es
Fabio Bandini
@nl
Fabio Bandini
@sl
P106
P1153
7004363066
P21
P31
P496
0000-0002-1104-459X